subject: Usna, Mslp.ob, & Matk: Musclepharm's Performance Products Are Gaining A Real Industry Interest [print this page] USANA Health Sciences, IncUSANA Health Sciences, Inc. (NASDAQ: USNA)
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, and the United Kingdom.
USANA Health Sciences has recently recorded their financial results for its fiscal second quarter ended July 3, 2010.
Net sales in the second quarter of 2010 improved 12.4% to $126.0 million, compared with $112.1 million in the second quarter of the prior year. This increase was due to an overall increase in product sales, driven primarily by a 5% increase in the number of active Associates, which is the result of continued growth in the Asia Pacific region. Additionally, favorable changes in currency exchange rates accounted for $5.2 million of the increase in net sales for the second quarter of 2010.
Net earnings in the second quarter of 2010 increased 22.5% to $10.8 million, or $0.69 per share, compared with $8.8 million, or $0.57 per share, in the second quarter of the prior year. This year-over-year increase resulted from higher net sales and improved gross profit margins. These improvements, however, were partially offset by higher Associate incentives expenses and higher selling, general and administrative expenses.
__________________________________
MusclePharm Corporation (OTCBB:MSLP)
MusclePharms top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed eight products: ASSAULT, BATTLE FUEL, BULLET PROOF, COMBAT POWDER, RECON, SHRED MATRIX, and MUSCLEGEL. Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma root the Russian Secret. Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.
MusclePharm is a fast-growing nutritional supplement company that offers products with up to twice as much of the active ingredients per serving as competing products and they incorporate a proprietary mix of ingredients that are not available elsewhere, such as Suma root the Russian Secret. Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.
Recently MusclePharm has secured an exclusive partnership with PSI a distributor in the Australian market which is a strategic move in taking advantage of the exposure the UFC partnership has created for MusclePharm. MusclePharm Executive Vice President Leonard Armenta said. We hope to leverage the popularity of the sport, expanding our distribution networks, resulting in increased brand awareness and sales. The UFC audience shows the passionate and loyal qualities that we are targeting for our products.
Australia is home to the second-fastest sellout in UFC history, as more than 16,000 tickets were sold on the first day for UFC 110 in February and is the third largest pay per view country for UFC events. It quickly has made Australia an annual destination for UFC events and that surge in popularity has helped grow the MusclePharm brand, which has aligned itself closely with the UFC and the sport of MMA.
UFC stands for the Ultimate Fighting Championship it is the worlds leading mixed martial arts sports association, formed in January 2001 by the Las Vegas sports promotion company Zuffa, LLC. Mixed martial arts is a combat sport in which competitors use interdisciplinary forms of fighting that include jiu-jitsu, judo, karate, boxing, kickboxing, and wrestling in a supervised match. Scoring for mixed martial arts events in Nevada, New Jersey, Massachusetts and Florida is based on athletic-commission approved definitions and rules for striking (blows with the hands, feet, knees or elbows) and grappling (submission, choke holds, throws or takedowns).The audience will probably need this nutritional drink more so than the fighters.
__________________________________
Martek Biosciences Corporation (Nasdaq: MATK)
Martek Biosciences Corporation is a leading innovator in the development of nutritional products that promote health and wellness through every stage of life. Martek has become a leader in fermentation technology and is an innovator in the research and development of products derived from microalgae. Dedicated to advancing both science and health for better lives everywhere, Martek continues to expand its research pipeline and development capabilities.
Martek Biosciences is a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition. The company's technology platform consists of its core expertise, broad experience and proprietary technology in areas such as microbial biology, algal genomics, fermentation and oil processing. This technology platform has resulted in Martek's development of a number of products including the company's flagship product, life'sDHA(TM), a sustainable and vegetarian source of algal DHA (docosahexaenoic acid) important for brain, heart and eye health throughout life for use in infant formula, pregnancy and nursing products, foods and beverages and dietary supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula and growing-up milks. Martek's subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products and holds leading brand positions in all of its key product categories. Amerifit products are sold in most major mass, club, drug, grocery and specialty stores and include: Culturelle(R), a leading probiotic supplement; AZO, the leading OTC brand addressing symptom relief, detection and prevention of urinary tract infections; and ESTROVEN(R), the leading all-natural nutritional supplement brand addressing the symptoms of menopause. Martek currently has a number of nutritional health and wellness products under development that it plans to commercialize and distribute through Amerifit's distribution channels.
Martek Biosciences has recently reported that it will be presenting at the Canaccord Genuity 30th Annual Growth Conference scheduled to take place August 10-12, 2010 in Boston, MA. Steve Dubin, Chief Executive Officer, and Peter L. Buzy, Chief Financial Officer, are scheduled to present on August 11 at 11:30 a.m. Eastern Time.
*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. The fee may be in cash, in free trading stock, in restricted stock, or in any combination thereof. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB)
